|
(V1184) |
The Platelet Inflammasome as a Protagonist of Vascular Inflammation |
|
|
D. Lievens, A. Baja, D. Projahn, P. von Hundelshausen, C. Weber (München) |
|
|
Diskussion |
|
(V1185) |
Soluble Junctional Adhesion Molecule-A Modulates Haemostatic, Thrombotic and Inflammatory Functions of Platelets through JAM-1 or F11 Receptor on Platelet Surface |
|
|
M. Chatterjee, J. Schwartz, V. Rapp, T. Stehle, M. Gawaz (Tübingen) |
|
|
Diskussion |
|
(V1186) |
Complement C3 and hypofibrinolysis: A potential role for protein glycation |
|
|
K. Schütt, R. King, F. Phoenix, K. Smith, S. Maxeiner, K. Lysaja, V. Jankowski, N. Marx, R. Ajjan (Aachen; Leeds, UK) |
|
|
Diskussion |
|
(V1187) |
Platelet-Derived-Gremlin-1 Modulates Monocyte Functions and Contributes to Circulatory Levels in Acute Coronary Syndrome |
|
|
M. Chatterjee, S. Beck, A. Behrendt, M. Schmid, T. Geisler, M. Gawaz (Tübingen) |
|
|
Diskussion |
|
(V1188) |
Micro RNA 181b links vascular inflammation and thrombogenicity by regulating the alternative splicing of Tissue Factor isoforms. |
|
|
M. Witkowski, A. Weithäuser, A. Eisenreich, D. Steffens, U. Landmesser, U. Rauch-Kröhnert (Berlin) |
|
|
Diskussion |
|
(V1189) |
Targeting the Nuclear Receptor PPARdelta as Novel Strategy to Prevent In-Stent Restenosis and Stent Thrombosis |
|
|
J. Hytonen, O. Leppänen, J.-H. Bräsen, D. Müller, W.-H. Schunck, F. Krackhardt, S. Ylae-Herttuala, F. Blaschke (Kuopio, FI; Kiel, Berlin) |
|
|
Diskussion |